Kathy Lien | Jul 14, 2020 21:15
Over the past few weeks, the euro has been one of the best performing currencies. It rose to a nearly four-month high versus the U.S. dollar despite weaker-than-expected economic data. Eurozone industrial production rose only 12.4% against a 15% forecast. The expectations component of the German ZEW survey dropped to 59.3 from 63.4. The current conditions component rose to -80.9 from -83.1, but economists were looking for a much more significant improvement to -65. The Eurozone ZEW survey ticked up slightly to 59.6 from 58.6. These numbers tell us that while the Eurozone is beginning to recover, investor sentiment remains subdued. At best, investors anticipate a gradual recovery, which is reasonable because the surge in cases in the U.S. prevents a stronger global recovery.
With that in mind, the outlook for the Eurozone is still brighter than other parts of the world, as they successfully controlled the spread of COVID-19. Italy, one of the countries hit the hardest by the virus reported only 114 new cases today, its lowest since February. Yesterday, Germany reported only 159 cases, but that number increased to 412 on Tuesday. Investors are still worried about a second wave in Europe, especially with borders reopening and tourism resuming. Spain reported a surge in cases on Monday leading the government to return to a flexible stage-two lockdown for areas affected. These numbers still pale in comparison to the huge numbers reported in the U.S. on a daily basis.
The greenback traded lower against most of the major currencies despite stronger consumer prices. Stocks continued to rally on Tuesday after biotech firm Moderna (NASDAQ:MRNA) announced that it will be starting phase 3 of its COVID-19 vaccine trials at the end of the month, joining Pfizer (NYSE:PFE) and BioNTech. The hope for a vaccine trumps everything else, including the massive loss reported by Wells Fargo (NYSE:WFC). Citigroup (NYSE:C) and JPMorgan (NYSE:JPM) reported significantly weaker earnings, while Delta (NYSE:DAL) said sales plummeted 88%. The Empire State manufacturing survey and Federal Reserve Beige Book are scheduled for release tomorrow. Economists are looking for improvements in manufacturing activity, but softer numbers or a more subdued Beige Book could reverse the gains in equities, triggering a sell-off in currencies.
Sterling sold off on the back of softer monthly GDP and industrial production numbers. The Australian dollar traded higher on the back of stronger business confidence and Chinese trade data. Despite Australian and Chinese trade tensions, China’s demand for coal and iron has increased significantly. Iron ore imports into China rose 10% in the first half of the year, while coal imports rose 13%. The New Zealand dollar fell despite stronger housing data.
The focus will be on the Canadian dollar tomorrow with a Bank of Canada rate decision on the calendar. This will be the very first meeting for Governor Tiff Macklem, who succeeded Stephen Poloz last month. When the central bank last met, it issued its latest economic projections, which were less pessimistic. Earlier this year, it expected the economy to contract by 22%, but altered that to -12%. It will be interesting to see if Macklem’s outlook differs. In mid-June, he said it will be a long time before the central bank removes stimulus as it's going to be a long, slow recovery. The country avoided the worse-case scenario, but don’t know how much damage there is to the economy. As such, the BoC can scale existing programs if needed.
Since the BoC's last meeting in June, Canada has flattened the curve, with only 222 cases reported over the weekend. The table below shows the fruits of the labor, with employment, housing and manufacturing activity improving. Unfortunately, the country’s proximity to the U.S. and its economic reliance on its southern neighbor means the outlook is uncertain, so chances are Macklem won’t be overly optimistic. USD/CAD has been slowly inching upwards over the past few days, so renewed concerns could drive it to 1.37.
Written By: Kathy Lien
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.
More content, faster quotes and charts, and a smoother experience is available only on the App.